Certified by Founder Lodge
Tome Biosciences
United States - Watertown, Massachusetts
START UP
1 Disclosed Funding Rounds $213,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Tome Biosciences is the programmable genomic integration (PGI) company. Our technologies allow us to insert any genetic sequence of any size at any location in the genome with site-specific p
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 14 ,2023 | Series B | $213,000,000 |
GV (Google Ventures)
ARCH Venture Partners
Polaris Partners
Alexandria Real Estate Equities, Inc.
a16z Bio + Health
Longwood Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
